ENTRY       D11861            Mixture   Drug
NAME        Indacaterol acetate, glycopyrronium bromide and mometasone furoate;
            Enerzair (TN)
COMPONENT   Indacaterol acetate [DR:D11009], Glycopyrrolate [DR:D00540], Mometasone furoate [DR:D00690]
REMARK      Therapeutic category: 2290
            ATC code: R03AL12
            Product: D11861<JP>
EFFICACY    Antiasthmatic
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03A ADRENERGICS, INHALANTS
                R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
                 R03AL12 Indacaterol, glycopyrronium bromide and mometasone
                  D11861  Indacaterol acetate, glycopyrronium bromide and mometasone furoate &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               229  Miscellaneous
                2290  Miscellaneous
                 D11861  Indacaterol acetate, glycopyrronium bromide and mometasone furoate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11861
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11861
///
